The Epidemiological Situation and Clinical Characteristic Aspect Cause by COVID-19 in Suspected Cases in Albania

Oltiana Petri; Erjona Abazaj; Albana Daka; Gentian Huti; Edmond Puca; Blerta Brati

doi:10.3889/oamjms.2022.8824

Authors

Oltiana Petri Infection Diseases and American Laboratory Network, American Hospital, Tirana, Albania; Department of Bioscience and Human Discipline, Sports University of Tirana, Albania https://orcid.org/0000-0003-2386-4605
Erjona Abazaj National Reference Laboratories, Institute of Public Health, Tirana, Albania https://orcid.org/0000-0003-2386-4605
Albana Daka Infection Diseases and American Laboratory Network, American Hospital, Tirana, Albania
Gentian Huti Infection Diseases and American Laboratory Network, American Hospital, Tirana, Albania https://orcid.org/0000-0002-5539-0136
Edmond Puca Infection Diseases and American Laboratory Network, American Hospital, Tirana, Albania https://orcid.org/0000-0002-0621-4865
Blerta Brati National Reference Laboratories, Institute of Public Health, Tirana, Albania

DOI:

https://doi.org/10.3889/oamjms.2022.8824

Keywords:

Severe acute respiratory syndrome coronavirus 2019, Epidemiological situation, American hospital patients

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has forcefully entered our lives and profoundly changed the perception and habits of the world population since the December 2019.

AIM: The aims of this study were to presents the epidemiology data and clinical characteristic aspect of patients suspected with COVID-19 and analyzed in the American laboratory in Tirana, Albania from August 2020 to March 2021.

METHODS: This study includes 1205 suspected cases for SARS COVID-19. Professionally trained health workers collected the samples from suspected patients by using synthetic fiber swabs. Double specimens from nasopharyngeal and pharyngeal swabs were collected from each of person. A standard questionnaire about the demographic and clinical data was filled for each person. The software SPSS version 22.0 was used for analyzing all data and also the examination findings.

RESULTS: The prevalence of SARS COVID-19 resulted to be 31.1%. The average age resulted 42.17 ± 18.6. The most predominant positive age resulted the age groups 31–40 years old and 41–50 years old with positivity 17.3% and 16.3%, respectively, with significant association p = 0.01. Male were the most analyzed and affected persons (61.6%) in this study with a strong significant association p = 0.0004. It turned out that more than half of patients refereed at least two symptoms in the same time of analyze and about 1/3 refereed more than three symptoms. We found an association for presence of all typical symptoms with positivity except the temperature. We identified that for all of these symptoms, the p value resulted less than 0.05.

CONCLUSION: SARS COVID-19 in the early stages of the disease is highly contagious. For this reason, the screening of people with symptoms is recommended to determine who should be quarantined and be tested. In this manner, we can decrease the rate of infection and protect healthy people from infection.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316.3.

Centers for Disease Control and Prevention. CDC 2019 Novel Coronavirus, Wuhan, China. Atlanta, Georgia: Centers for Disease Control and Prevention; 2020. Available from: https:// www.cdc.gov/coronavirus/2019-nCoV/summary.html [Last accessed on 2020 Feb 01].

World Health Organization. Novel Coronavirus-China. Geneva: World Health Organization; 2020. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en [Last accessed on 2020 Feb 01].

Nicks BA, Wong O. Coronavirus Disease 2019 (COVID-19): A Global Crisis. Available from: https://www.medscape.com/slideshow/2019-novel-coronavirus-6012559 [Last accessed on 2020 Apr 02].

Chatterjee P, Nagi N, Agarwal A, Das B, Banerjee S, Sarkar S, et al. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. Indian J Med Res. 2020;151(2-3):147-59. https://doi.org/10.4103/ijmr.ijmr_519_20 PMid:32362642 DOI: https://doi.org/10.4103/ijmr.IJMR_519_20

Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281-6. https://doi.org/10.1007/s12098-020-03263-6 PMid:32166607 DOI: https://doi.org/10.1007/s12098-020-03263-6

World Health Organization. Corona-virus Disease (COVID-19) Outbreak. Geneva: World Health Organization. Available from: https://www.who.int/[Last accessed on 2021 Feb 16].

World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report-12. Geneva: World Health Organization; 2020. p. 7.

Wong SH, Lui RN, Sung JJ. COVID-19 and the digestive system. J Gastroenterol Hepatol. 2020;35:744-8. DOI: https://doi.org/10.1111/jgh.15047

Yan CH, Faraji F, Prajapati DP, Boone EC, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806-13. https://doi.org/10.1002/alr.22579 PMid:32279441 DOI: https://doi.org/10.1002/alr.22579

Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382(20):e60. DOI: https://doi.org/10.1056/NEJMc2009787

World Health Organization. Laboratory Testing For Coronavirus Disease (Covid-19) in Suspected Human Cases: Interim Guidance, 19 March 2020. Geneva: World Health Organization. 2020. p. 7. Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 [Last accessed on 2021 Apr 02].

World Health Organization. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Last accessed on 2021 Apr 02].

Canning D, Karra M, Dayalu R, Guo M, Bloom DE. The association between age, COVID-19 symptoms, and social distancing behavior in the United States. Preprint. medRxiv. 2020;2020:1-23. https://doi.org/10.1101/2020.04.19.20065219. PMid:32511621 DOI: https://doi.org/10.1101/2020.04.19.20065219

Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T, et al. Epidemiology of SARS-CoV-2. Infection. 2021;49(2):233-9. https://doi.org/10.1007/s15010-020-01531-3 PMid:33034020 DOI: https://doi.org/10.1007/s15010-020-01531-3

Goujon A, Natale F, Ghio D, Conte A, Dijkstra L. Age, Gender, and Territory of COVID-19 Infections and Fatalities, EUR 30237 EN. Luxembourg: Publications Office of the European Union; 2020.

Elimian KO, Ochu CL, Ebhodaghe B, Myles P, Crawford EE, Igumbor E, et al. Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: Retrospective cohort study. BMJ Open. 2020;10(12):e044079. https://doi.org/10.1136/bmjopen-2020-044079 PMid:33334842

de Lusignan S, Dorward J, Correa A, Jones N, Akinyemi O, Amirthalingam G, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: A cross-sectional study. Lancet Infect Dis. 2020;20(9):1034-2. https://doi.org/10.1016/s1473-3099(20)30371-6 PMid:32422204 DOI: https://doi.org/10.1016/S1473-3099(20)30371-6

Kolifarhood G, Aghaali M, Saadati HM, Taherpour N, Rahimi S, Izadi N, et al. Epidemiological and clinical aspects of COVID-19; A narrative review. Arch Acad Emerg Med. 2020;8(1):e41. PMid:32259130

Wong JEL, Leo YS, Tan CC. COVID-19 in Singapore-current experience: Critical global issues that require attention and action. JAMA. 2020;323(13):1243-4. https://doi.org/10.1001/jama.2020.2467 PMid:32077901 DOI: https://doi.org/10.1001/jama.2020.2467

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020;7(2):91-6. https://doi.org/10.1515/dx-2020-0046 PMid:32352401 DOI: https://doi.org/10.1515/dx-2020-0046